Outcome Analysis of the Oxford Partial Knee Arthroplasty

This study has been completed.
Dartmouth General Hospital
Information provided by (Responsible Party):
Biomet, Inc.
ClinicalTrials.gov Identifier:
First received: September 24, 2008
Last updated: February 11, 2012
Last verified: February 2012
Prospectively monitor the patients receiving the Oxford Partial knee arthroplasty

Condition Intervention
Knee Arthroplasty
Device: Oxford Partial Knee

Study Type: Interventional
Study Design: Endpoint Classification: Safety/Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Outcome Analysis of the Oxford Partial Knee Arthroplasty

Resource links provided by NLM:

Further study details as provided by Biomet, Inc.:

Primary Outcome Measures:
  • WOMAC, SF12, oxford Knee,KSCRS [ Time Frame: 3weeks, 3months,6months, yearly ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Length of Hospital Stay [ Time Frame: Postop ] [ Designated as safety issue: No ]

Enrollment: 156
Study Start Date: April 2003
Study Completion Date: June 2009
Primary Completion Date: June 2009 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: 1 Device: Oxford Partial Knee
Oxford Partial Knee

Detailed Description:
Utilization of systematic outcome measurements and specific designated time frames to monitor patient satisfactions will assist in analysing this type of prosthesis and the post operative period. Data collected will be added to the compiled information from previous studies in relation to the Oxford knee.

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Patient Suitable for Knee Replacement

Exclusion Criteria:

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00759616

Dartmouth General Hospital
Dartmouth, Canada
Sponsors and Collaborators
Biomet, Inc.
Dartmouth General Hospital
  More Information

Responsible Party: Biomet, Inc.
ClinicalTrials.gov Identifier: NCT00759616     History of Changes
Other Study ID Numbers: BMET CA 03 
Study First Received: September 24, 2008
Last Updated: February 11, 2012
Health Authority: Canada: Ethics Review Committee

Keywords provided by Biomet, Inc.:
Knee Replacement

ClinicalTrials.gov processed this record on May 25, 2016